F17L (p.Phe17Leu) variant of KRT1 (Keratin, type II cytoskeletal 1)
F17L (p.Phe17Leu) in KRT1 (Keratin, type II cytoskeletal 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes structural context.
F17L (p.Phe17Leu) variant details
- p.Phe17Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- UniProt: Variant assessed as somatic; high impact.
- Structural context available